IJCRR - Vol 08 Issue 19, October, 2016
SEROPOSITIVITY OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS AMONG BLOOD DONORS AT A TERTIARY CARE HOSPITAL IN KASHMIR: A TEN-YEAR STUDY
Author: Mohammad Zubair Qureshi, Humaira Bashir, Peer Maroof, Samoon Jeelani, Nazia Bhat, Fehmeeda Akhter
Objectives: Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are important transfusion-transmissible infections. This study was performed to assess the Seropositivity of HBV and HCV Seropositivity among blood donors at a Tertiary Care Hospital based blood bank at SKIMS, Kashmir.
Materials and Methods: The blood donation records over 10 years from Jan- 2003 to Dec-2012 were reviewed, retrospectively, for the seropositivity and yearly trends of HBV and HCV.
Results: A total of 97427 donations were received. The overall number of HBV seropositive donations was 469 and that for HCV was 194, with the seroprevalence rates of 0.48% for hepatitis B surface antigen (HBsAg) and 0.20% for HCV. The seropositivity rate was higher in the replacement donors compared to the voluntary donors and 0% in repeat voluntary donors. The annual rates showed decreasing trends for both HBsAg and HCV.
Conclusion: The seropositivity of viral markers was lower in our study as compared with studies from other parts of the country. It was significantly lower in voluntary donors compared to replacement donors and repeat voluntary donors were found to be much safer.
Keywords: Hepatitis B virus, Hepatitis C virus, Seropositivity, Hepatitis B Surface Antigen
Mohammad Zubair Qureshi, Humaira Bashir, Peer Maroof, Samoon Jeelani, Nazia Bhat, Fehmeeda Akhter. SEROPOSITIVITY OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS AMONG BLOOD DONORS AT A TERTIARY CARE HOSPITAL IN KASHMIR: A TEN-YEAR STUDY International Journal of Current Research and Review. Vol 08 Issue 19, October, 17-20
1. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion transmitted infections among multitransfused patients in Iran: a review. Transfuse Med 2007; 17(6):425–33.
2. Livramento A, Cordova CM, Spada C, Treitinger A. Seroprevalence of hepatitis
B and C infection markers among children and adolescentsin the southern Brazilian region. Rev Inst Med Trop Sao Paulo 2011; 53(1) :13-7.
3. Simmonds P.The origin and evolution of hepatitis viruses in humans. J Gen Virol 2001;82:693-712.
4. YeeTT, Lee CA. Transfusion transmitted infection in hemophilia in developing countries. Semin Thromb Hemost. 2005; 31(5):527-37.
5. Samimi-Rad K , Shahbaz B. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia 2007;13(2):156-63.
6. Burki MF, Hassan M, Hussain H, Nisar Y, Krishan J. Prevalence of anti-hepatitis C antibodies in multiply transfused beta thalassemia major patients. Ann Pak Inst Med Sci 2005;1:150-3.
7. Kleinman SH, Lelie N, Busch MP. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009;49:2454-89.
8. Mukhopadhyaya A. Hepatitis C in India. J Biosci 2008;33:465-73.
9. Datta S. An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virol J 2008;5:156.
10. Gupta N, Kumar V, Kaur A. Seroprevalence of HIV, HBV,HCV and syphilis in voluntary blood donors. Indian J Med Sci 2004;58:255-7.
11. Panda M, Kar K. HIV, hepatitis B and C infection status of the blood donors in a blood bank of a tertiary health care centre of Orissa. Indian J Public Health 2008;52:43-4.
12. Pahuja S, Sharma M, Baitha B, Jain M. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study. Jpn J Infect Dis 2007;60:389-91.
13. Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol 2001;44:409-12.
14. WHO. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention Board, Antwerp, Belgium. J Viral Hepat 1999;6:35-47.
15. Sood G, Chauhan A, Sehgal S, Agnihotri S, Dilawari JB. Antibodies to hepatitis C virus in blood donors. Indian JGastroenterol 1992;11:44.
16. Beenu T, Nelam M, Chawla YK et al. Prevalence and significance of hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res. 2006 (Oct.); 124:431-438.